About the Foundation

The Foundation for Cancer Research Support (RakFond) is a non-profit organization whose main tasks include: financing research and development activities, development of new methods and tools for the prevention, diagnosis and treatment of cancer, promoting the development and improvement of research and scientific activities of research institutions, scientific centers, oncological hospitals, and individual specialists in the field of oncology. The Foundation was founded in 2017 and operates on the territory of the Russian Federation.

NEWS

VIEW ALL

15 Nov

NEWS OF THE XXIII RUSSIAN ONCOLOGY CONGRESS

В первый день XXIII Российского онкологического конгресса РакФонд и Российское общество клинической онкологии провели совместный мастер-класс, посвященный клиническим исследованиям в онкологии далее...

12 Nov

RAKFOND AND RUSSCO AWARD FOR THE BEST RESEARCH

Today, November 12, at the opening ceremony of the XXIII Russian Oncology Congress, the results of the selection of the best research presented at the session “Russian Research Results” were announced. далее...

6 Nov

NEWS OF THE ESMO 2019 CONGRESS: ONCOGYNECOLOGY AND BREAST CANCER TREATMENT

By Alexey Rumyantsev, MD, Department of Chemotherapy and Clinical Oncology, N.N. Blokhin National Medical Research Center of Oncology In September 2019, the ... далее...

9 Oct

The 2019 Nobel Prize Laureates in Physiology or Medicine

The announcement of the 2019 Nobel Prize laureates started on October 7, 2019. The 2019 Nobel Prize in Physiology or Medicine is awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability.” далее...

7 Oct

ДОКЛАД АМЕРИКАНСКОЙ АССОЦИАЦИИ ПО ИЗУЧЕНИЮ РАКА О ПРОГРЕССЕ В ОНКОЛОГИИ

ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

This September, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report, which highlights advances over the past year in the prevention, detection, diagnosis, and treatment of cancer. далее...

27 Sep

ESMO CONGRESS

The study by Alexey Rumyantsev, supported by the RUSSCO/RakFond grant, was cited at the ESMO Congress. далее...

Articles and Reviews

View All

HOW TO INITIATE YOUR OWN CLINICAL STUDY

This year, a joint workshop by RUSSCO and RakFond within the XXIII Russian Oncology Congress was dedicated to conducting clinical trials in oncology. Leading experts shared their experiences and discussed examples of what is needed to initiate your own clinical study. далее...

7 Oct

ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING

Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA... далее...

WHAT IS CLINICAL RESEARCH

RakFond's SAB Member Professor Nikolay Zhukov, MD, DSci, explains in this video what clinical research is, he describes different types of clinical studies, what they provide to medical doctors, and why taking part in clinical trials is important for patients... далее...

18 Jun

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II

Compiled by Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting... далее...

14 Jun

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I

The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting... далее...

Interviews with experts

RakFond's experts talk in their short interviews about their choice to become an oncologist, which cancer research they could name as their favorite, and why cancer research support is important.

Interview with Tatiana Semiglazova

Interview with Tatiana Semiglazova, MD, DSci, Professor, Head of Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N.N. Petrov National Medical Research Center of Oncology (St. Petersburg, Russia), Professor at the Department of Oncology, I.I. Mechnikov North-Western State Medical University (St. Petersburg, Russia)...The topic of the interview is the rehabilitation of cancer patients... далее...

Interview with Andrei Gudkov

Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond's Scientific Advisory Board... Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us... далее...

Interview with Katerina Gurova

Interview with Katerina Gurova, M.D., Ph.D., Professor of Oncology, Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA)... Learn about the regulation of reading in the library of genes, the role of the "gene of conscience"... далее...

Interview with Jacek Gronwald

Interview with Jacek Gronwald, PhD, Professor, Department of Genetics and Pathology, Pomeranian Medical University (Szczecin, Poland), Member of RakFond's Scientific Advisory Board. Learn about hereditary cancers, studies of lifestyle factors in oncology... далее...

Interview with Alexey Danilov

Interview with Alexey Danilov, Associate Professor of Medicine, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (Portland, USA), Member of RakFond's Scientific Advisory Board...Learn about research translation from bench to bedside, the discovery and research of the novel therapies in hematologic malignancies... далее...

Interview with Alexey Tryakin

Interview with Alexey Tryakin, M.D., D.Sci., Chief Scientist, Department of Clinical Pharmacology and Chemotherapy of N.N. Blokhin National Medical Research Center of Oncology (Moscow, Russia)... Learn about the inception of the targeted therapy in oncology, what advantages of participating in clinical trials bring to doctors and patients... далее...

About the Foundation

NEWS

NEWS OF THE XXIII RUSSIAN ONCOLOGY CONGRESS

RAKFOND AND RUSSCO AWARD FOR THE BEST RESEARCH

NEWS OF THE ESMO 2019 CONGRESS: ONCOGYNECOLOGY AND BREAST CANCER TREATMENT

The 2019 Nobel Prize Laureates in Physiology or Medicine

ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

ESMO CONGRESS

Articles and Reviews

HOW TO INITIATE YOUR OWN CLINICAL STUDY

ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING

WHAT IS CLINICAL RESEARCH

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I

Interviews with experts

Interview with Tatiana Semiglazova

Interview with Andrei Gudkov

Interview with Katerina Gurova

Interview with Jacek Gronwald

Interview with Alexey Danilov

Interview with Alexey Tryakin

Our Supporters

Spelling error report

The following text will be sent to our editors: